JP2024514352A5 - - Google Patents
Info
- Publication number
- JP2024514352A5 JP2024514352A5 JP2023564257A JP2023564257A JP2024514352A5 JP 2024514352 A5 JP2024514352 A5 JP 2024514352A5 JP 2023564257 A JP2023564257 A JP 2023564257A JP 2023564257 A JP2023564257 A JP 2023564257A JP 2024514352 A5 JP2024514352 A5 JP 2024514352A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- co2h
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21169757 | 2021-04-21 | ||
| EP21169757.8 | 2021-04-21 | ||
| PCT/IB2022/053698 WO2022224164A1 (en) | 2021-04-21 | 2022-04-20 | Glucagon like peptide compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514352A JP2024514352A (ja) | 2024-04-01 |
| JP2024514352A5 true JP2024514352A5 (cg-RX-API-DMAC7.html) | 2025-04-15 |
Family
ID=75639721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564257A Pending JP2024514352A (ja) | 2021-04-21 | 2022-04-20 | グルカゴン様ペプチド化合物 |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4048664A1 (en) | 2019-10-25 | 2022-08-31 | Gilead Sciences, Inc. | Glp-1r modulating compounds |
| EP4247804A1 (en) | 2020-11-20 | 2023-09-27 | Gilead Sciences, Inc. | Polyheterocyclic glp-1 r modulating compounds |
| IL306110A (en) | 2021-04-21 | 2023-11-01 | Gilead Sciences Inc | Carboxy-benzimidazole glp-1r modulating compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI362392B (en) | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| US10588980B2 (en) | 2014-06-23 | 2020-03-17 | Novartis Ag | Fatty acids and their use in conjugation to biomolecules |
| JP6730278B2 (ja) * | 2014-11-27 | 2020-07-29 | ノヴォ ノルディスク アー／エス | Ｇｌｐ−１誘導体及びその使用 |
| MA41580A (fr) * | 2015-01-23 | 2017-11-29 | Novartis Ag | Conjugués d'acides gras de l'apeline synthétique présentant une demi-vie améliorée |
-
2022
- 2022-04-19 TW TW111114875A patent/TW202304500A/zh unknown
- 2022-04-20 US US18/556,461 patent/US20240247042A1/en active Pending
- 2022-04-20 IL IL307822A patent/IL307822A/en unknown
- 2022-04-20 WO PCT/IB2022/053698 patent/WO2022224164A1/en not_active Ceased
- 2022-04-20 BR BR112023021597A patent/BR112023021597A2/pt unknown
- 2022-04-20 EP EP22719363.8A patent/EP4326330A1/en active Pending
- 2022-04-20 MX MX2023012290A patent/MX2023012290A/es unknown
- 2022-04-20 JP JP2023564257A patent/JP2024514352A/ja active Pending
- 2022-04-20 KR KR1020237039490A patent/KR20230171471A/ko active Pending
- 2022-04-20 CA CA3216058A patent/CA3216058A1/en active Pending
- 2022-04-20 CN CN202280029619.8A patent/CN117202936A/zh active Pending
- 2022-04-20 AU AU2022260805A patent/AU2022260805A1/en not_active Abandoned
- 2022-04-21 AR ARP220101035A patent/AR125400A1/es unknown
-
2023
- 2023-10-17 CL CL2023003091A patent/CL2023003091A1/es unknown